US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Spdr S&P Pharmaceuticals Etf

64.99

+1.362.14%

Volume:57.18K

Turnover:3.68M

Market Cap:477.69M

PE:25.17

High:65.02

Open:63.87

Low:63.54

Close:63.63

52wk High:74.35

52wk Low:46.90

Shares:7.35M

Float Shares:7.35M

Volume Ratio:0.25

T/O Rate:0.78%

Dividend:0.27

Dividend Rate:0.42%

EPS(TTM):2.58

EPS(LYR):-0.1280

ROE:42.40%

ROA:0.26%

PB:1.11

PE(LYR):-507.67

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Citi: Sino Biopharmaceutical and STADA Form Biosimilar Strategic Partnership, "Buy" Rating Maintained

Sino Biopharmaceutical Jumps Nearly 4% as Subsidiary Strikes Strategic Biosimilar Deal with STADA, Securing Up to EUR53 Million in Upfront Payment

Patent Expirations and R&D Gaps Create a Looming Biologic Shortfall, Potentially Costing the U.S. Healthcare System $189 Billion

Fosun Pharma's Subsidiary Sees Regulatory Acceptance for Denosumab Biosimilar Candidate HLX14

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/XPH"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"XPH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XPH\",,,,,undefined,":{"symbol":"XPH","market":"US","secType":"STK","nameCN":"Spdr S&P Pharmaceuticals Etf","latestPrice":64.99,"timestamp":1791568076043,"preClose":63.63,"halted":0,"volume":57176,"delay":0,"changeRate":0.02137356592802125,"floatShares":7350270,"shares":7350270,"eps":2.581957,"marketStatus":"Trading","change":1.36,"latestTime":"10-09 13:47:57 EDT","open":63.87,"high":65.02,"low":63.54,"amount":3680848.51176,"amplitude":0.023259,"askPrice":65.08,"askSize":900,"bidPrice":64.94,"bidSize":800,"shortable":3,"etf":1,"ttmEps":2.581957,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791576000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":63.63,"sharesOutstanding":5750270,"nav":62.968689,"aum":456539998.12,"dividendRate":0.00421,"bidAskSpread":0.002097,"preHourTrading":{"tag":"盘前","latestPrice":64,"preClose":63.63,"latestTime":"08:27 EDT","volume":50,"amount":3200,"timestamp":1791548837841,"change":0.37,"changeRate":0.005815,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":64.024,"preClose":63.63,"latestTime":"19:55 EDT","volume":119,"amount":7610.94,"timestamp":1791503710394,"change":0.394,"changeRate":0.006192,"amplitude":0.006192},"volumeRatio":0.251879,"impliedVol":0.1356,"impliedVolPercentile":0.3386},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XPH\",,,,,undefined,":{"symbol":"XPH","floatShares":7350270,"roa":"0.26%","roe":"42.40%","lyrEps":-0.128016,"volumeRatio":0.251879,"shares":7350270,"dividePrice":0.2736,"high":65.02,"amplitude":0.023259,"preClose":63.63,"low":63.54,"week52Low":46.9,"pbRate":"1.11","psRate":"218.04","week52High":74.345,"institutionHeld":0,"latestPrice":64.99,"committee":-0.058824,"eps":2.581957,"divideRate":0.00421,"volume":57176,"delay":0,"ttmEps":2.581957,"open":63.87,"prevYearClose":56.01,"prevWeekClose":63.64,"prevMonthClose":65,"prevQuarterClose":65,"fiveDayClose":63.64,"twentyDayClose":67.51,"sixtyDayClose":67.3},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XPH\",params:#limit:5,,,undefined,":[{"date":"2026-09-21","symbol":"XPH","amount":0.04164,"announcedDate":"2026-09-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-21","defaultRemindTime":1789997400000,"name":"SPDR S&P Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-23","payableDate":"2026-09-21","currency":"USD","dateTimestamp":1789963200000,"payDate":"2026-09-23"},{"date":"2026-06-22","symbol":"XPH","amount":0.059045,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"SPDR S&P Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-24","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-24"},{"date":"2026-03-23","symbol":"XPH","amount":0.060954,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"SPDR S&P Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-25","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-25"},{"date":"2025-12-22","symbol":"XPH","amount":0.113024,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"SPDR S&P Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XPH","amount":0.102634,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR S&P Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XPH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.091273,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.026956,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.085023,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-25","value":0.07227,"currency":"USD"},{"executeDate":"2018-03-16","recordDate":"2018-03-19","paymentDate":"2018-03-21","value":0.019429,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XPH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XPH\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1147221461","title":"Citi: Sino Biopharmaceutical and STADA Form Biosimilar Strategic Partnership, \"Buy\" Rating Maintained","url":"https://stock-news.laohu8.com/highlight/detail?id=1147221461","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147221461?lang=en_us&edition=fundamental","pubTime":"2026-09-29 16:54","pubTimestamp":1790672068,"startTime":"0","endTime":"0","summary":"Citi issued a research report stating that Sino Biopharmaceutical (01177), through its subsidiary Chia Tai Tianqing, has entered into a strategic partnership with German pharmaceutical company STADA...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","LU1992135472.HKD","BK1191","LU1244550494.USD","BK4534","BK4559","BK4504","LU0320765646.SGD","LU1144417596.USD","LU2473716301.USD","BK1589","LU2272731865.HKD","LU1162221912.USD","LU1791807156.HKD","LU2417539215.USD","LU1074936037.SGD","LU1244550577.SGD","LU2272731600.USD","LU2322448957.HKD","C","LU1366192091.USD","LU2360032135.SGD","LU0314106906.USD","IBB","LU0128525689.USD","IE00B5TLWC47.USD","LU0648001328.SGD","LU2125154778.USD","LU2456880835.USD","LU0980610538.SGD","LU1201861249.SGD","BK4588","LU2125154935.USD","LU2236285917.USD","LU2322448791.USD","LU0310800965.SGD","BK1521","LU0130517989.USD","FTXO","IE00BZ08YS42.EUR","LU0170899867.USD","LU0477156953.USD","LU1267930227.SGD","LU1506573853.SGD","01177","LU0162691827.USD","LU1992135399.USD","BK4207","BK1515","LU1668664300.SGD","IYF","IE00BSNM7G36.USD","LU0106831901.USD","IE00BZ08YT58.USD","IE00BZ08YR35.GBP","PPH","LU0052756011.USD","BK4585","HK0000165453.HKD","LU0072461881.USD","TFNS","LU2272731782.SGD","LU0203345920.USD","LU2462157665.USD","LU0203347892.USD","LU0130102774.USD","XPH","LU0098860793.USD","LU1244550221.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188705505","title":"Sino Biopharmaceutical Jumps Nearly 4% as Subsidiary Strikes Strategic Biosimilar Deal with STADA, Securing Up to EUR53 Million in Upfront Payment","url":"https://stock-news.laohu8.com/highlight/detail?id=1188705505","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188705505?lang=en_us&edition=fundamental","pubTime":"2026-09-29 10:03","pubTimestamp":1790647387,"startTime":"0","endTime":"0","summary":"Shares of Sino Biopharmaceutical (01177) climbed nearly 4%, rising 3.64% to HK$5.695 as of press time, with turnover reaching HK$89.7588 million.On the news front, Sino Biopharmaceutical announced...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B5TLWC47.USD","BK1521","MEURmain","VXUS","IE00BZ08YT58.USD","FXE","BK4588","LU2473716301.USD","LU1992135399.USD","LU2322448957.HKD","IE00BZ08YS42.EUR","KCAI","EUO","HK0000165453.HKD","BK1589","NBIE","LU2322448791.USD","LU2272731865.HKD","LU2272731600.USD","LU1992135472.HKD","IBB","BK1515","XPH","01177","IE00BZ08YR35.GBP","EURmain","PPH","BK4585","LU2272731782.SGD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131230465","title":"Patent Expirations and R&D Gaps Create a Looming Biologic Shortfall, Potentially Costing the U.S. Healthcare System $189 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1131230465","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131230465?lang=en_us&edition=fundamental","pubTime":"2026-09-18 09:54","pubTimestamp":1789696466,"startTime":"0","endTime":"0","summary":"A recent industry analysis warns that over the next decade, nearly 90% of biologic drugs losing their market exclusivity will lack a corresponding biosimilar in development, creating a significant...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2322448791.USD","PPH","IE00B5TLWC47.USD","LU2272731782.SGD","LU2473716301.USD","BK4585","LU1992135399.USD","LU1992135472.HKD","LU2272731865.HKD","LU2322448957.HKD","XPH","BK4588","LU2272731600.USD","159891","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188259168","title":"Fosun Pharma's Subsidiary Sees Regulatory Acceptance for Denosumab Biosimilar Candidate HLX14","url":"https://stock-news.laohu8.com/highlight/detail?id=1188259168","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188259168?lang=en_us&edition=fundamental","pubTime":"2026-09-11 17:50","pubTimestamp":1789120228,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196.SH) has announced that the drug registration application for its self-developed denosumab biosimilar, HLX14 (recombinant anti-RANKL fully human...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","LU1992135472.HKD","LU1992135399.USD","LU2473716301.USD","BK0196","IBB","BK4588","LU2322448791.USD","LU2272731782.SGD","BK0183","BK0187","PPH","LU2322448957.HKD","02196","BK1515","XPH","BK4585","BK0175","BK0028","BK1593","BK0096","BK0239","IE00B5TLWC47.USD","BK0188","BK0060","LU2272731600.USD","600196","BK0012","LU2272731865.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":11,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/XPH\",params:#limit:6,delay:false,,,undefined,":[]}}